The largest database of trusted experimental protocols

Caliper ivis

Manufactured by PerkinElmer
Sourced in United States

The Caliper IVIS is a high-performance in vivo imaging system designed for preclinical research. It provides researchers with the ability to detect and quantify light-emitting reporter molecules within living subjects. The Caliper IVIS system combines sensitive optical detection, automated image acquisition, and advanced analysis software to enable non-invasive, longitudinal monitoring of biological processes in small animal models.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using caliper ivis

1

Nanoparticle-mediated delivery to the round window membrane

Check if the same lab product or an alternative is used in the 5 most similar protocols
Guinea pigs were killed to sample the acoustic bullae (including the RWM). The acoustic bullae were placed in solution of FBSA and BSA NPs (the preparation of which was described in another paper by the same authors being reviewed) and shaken for 30 minutes at 37°C. The air-dried specimens were observed by SEM.
The penetration of RhB released from the particles was evaluated by living images and microscopes. The same amount of RhB was incubated with FBSA-H particles and BSA NPs in the preparation of FBSA-RhB and BSA-NP-RhB. Guinea pigs were anesthetized, and the RWMs were exposed. The FBSA-RhB and BSA-NP-RhB particles dispersed in phosphate-buffered saline were injected slowly into the bulla of the right and left ear, respectively. The left ear injected with BSA-NP-RhB was the control. An in vivo imaging system (Caliper IVIS®; PerkinElmer, Waltham, MA, USA) was used to trace the particles at time points of 0 and 48 hours. RWMs were then imaged by fluorescence microscopy to observe the distribution of RhB on them. Several days later, RWMs with particles were observed by SEM.
+ Open protocol
+ Expand
2

In vivo Nanoparticle Biodistribution Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vivo distribution of PPD NPs and PP NPs were evaluated by the 4T1 tumor-bearing Balb/c mice. When the tumors were up to 300 mm3, the mice were randomly divided into two groups. Cy7-labeled PP NPs and PPD NPs were intravenously administrated at an equivalent dose of 2 mg/kg Cy7. Then, the mice were sacrificed at 4 h and 24 h, and the major organs and tumors were imaged under caliper IVIS (PerkinElmer, USA). As such, the tumors were stained with LDLr primary antibody overnight at 4 °C and Alexa Fluor 488 conjugated anti-rabbit IgG secondary antibody, DAPI and then visualized with CLSM [30] (link).
+ Open protocol
+ Expand
3

Biodistribution of DiR-Labeled Liposomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biodistribution was investigated in B16-F10 melanoma bearing mice. When the tumor volume reached about 500 mm3, DiR solution and DiR labeled liposomes were administered intravenously at a dose equivalent of 2 mg/kg. After administration for 4, 12 and 24 h, mice were sacrificed. The major organs and tumors were collected for ex vivo imaging by Caliper IVIS (Perkin Elmer, USA).
+ Open protocol
+ Expand
4

Tracking DOX-Platelet-CD22 Interactions In Vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the effects of DOX–platelet–CD22 in vivo, we first established a tumor-bearing mouse model via subcutaneous injections with 2 × 107 Raji cells/mL in 200 μL of PBS. When tumor sizes reached 80–150 mm3, the mice were randomly assigned into three groups: (1) DOX, (2) DOX–platelet, and (3) DOX–platelet–CD22. Each mouse received 200 μL of the treatment agents (8 mg/kg DOX for the detection of its autofluorescence) via intravenous administration. The mice were imaged with DOX autofluorescence (excitation wavelength of 485 nm and emission wavelength of 585 nm) and FITC-labeled anti-CD22 mAbs (excitation wavelength of 488 nm, emission wavelength of 525 nm). The mice were anesthetized and imaged using a Caliper IVIS (PerkinElmer) at 24 h after injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!